Clinical Trials Browser

Phase 2 × INDUSTRY × fulranumab × Clear all

NCT00929188 2016-01-22

A Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Cancer-related Pain

Phase 2 Completed

Cancer Pain, Pain